{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T22:22:53Z","timestamp":1787696573523,"version":"build-2784847793"},"reference-count":108,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dermatologic Clinics"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1016\/j.det.2010.03.003","type":"journal-article","created":{"date-parts":[[2010,5,28]],"date-time":"2010-05-28T06:01:09Z","timestamp":1275026469000},"page":"577-586","source":"Crossref","is-referenced-by-count":63,"title":["Innovative Uses of Thalidomide"],"prefix":"10.1016","volume":"28","author":[{"given":"Meng","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean D.","family":"Doherty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7\u20138","key":"10.1016\/j.det.2010.03.003_bib1","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.biocel.2007.01.022","article-title":"The thalidomide saga","volume":"39","author":"Melchert","year":"2007","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.det.2010.03.003_bib2","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1056\/NEJM196212062672305","article-title":"The saga of thalidomide. Neuropathy to embropathy, with case reports of congenital abnormalities","volume":"267","author":"Mellin","year":"1962","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.det.2010.03.003_bib3","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1365-2133.2005.06747.x","article-title":"Thalidomide: dermatological indications, mechanisms of action and side-effects","volume":"153","author":"Wu","year":"2005","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.det.2010.03.003_bib4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.5070\/D35FK5W0QV","article-title":"A review of thalidomide's history and current dermatological applications","volume":"9","author":"Perri","year":"2003","journal-title":"Dermatol Online J"},{"issue":"4","key":"10.1016\/j.det.2010.03.003_bib5","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1529-8019.2007.00132.x","article-title":"Dermatologic therapeutics: thalidomide. A practical guide","volume":"20","author":"Rosenbach","year":"2007","journal-title":"Dermatol Ther."},{"key":"10.1016\/j.det.2010.03.003_bib6","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/tera.1420380305","article-title":"Thalidomide update: regulatory aspects","volume":"38","author":"Kelsey","year":"1988","journal-title":"Teratology"},{"issue":"4","key":"10.1016\/j.det.2010.03.003_bib7","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S1085-5629(98)80019-9","article-title":"Thalidomide and its impact in dermatology","volume":"17","author":"Stirling","year":"1988","journal-title":"Semin Cutan Med Surgery"},{"key":"10.1016\/j.det.2010.03.003_bib8","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0733-8635(05)70232-1","article-title":"Thalidomide","volume":"19","author":"Radomsky","year":"2001","journal-title":"Dermatol Clin"},{"issue":"5","key":"10.1016\/j.det.2010.03.003_bib9","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1046\/j.1523-1747.1999.00744.x","article-title":"Thalidomide increases human keratinocyte migration and proliferation","volume":"113","author":"Nasca","year":"1999","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.det.2010.03.003_bib10","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1001\/archderm.115.5.636c","article-title":"Thalidomide in the treatment of recurrent, necrotic, and giant mucocutaneous aphthae and apthosis","volume":"115","author":"Mascaro","year":"1979","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2010.03.003_bib11","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/S0140-6736(84)91622-2","article-title":"Thalidomide in severe orogenital ulceration","volume":"2","author":"Jenkins","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.det.2010.03.003_bib12","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0190-9622(85)70014-X","article-title":"Significant response of oral aphthosis to thalidomide treatment","volume":"12","author":"Grinspan","year":"1985","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.det.2010.03.003_bib13","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1001\/archderm.126.7.923","article-title":"Crossover study of thalidomide vs placebo in severe recurrent aphthous stomatitis","volume":"126","author":"Revuz","year":"1990","journal-title":"Arch Dermatol"},{"issue":"3","key":"10.1016\/j.det.2010.03.003_bib14","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1590\/S1807-59322009000300008","article-title":"Systemic treatment in severe cases of recurrent aphthous stomatitis: an open trial","volume":"64","author":"Mimura","year":"2009","journal-title":"Clinics (Sao Paulo)"},{"key":"10.1016\/j.det.2010.03.003_bib15","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1056\/NEJM199705223362103","article-title":"Thalidomide for the treatment of oral aphthous ulcers in patients with human immunodeficiency virus infection","volume":"336","author":"Jacobson","year":"1997","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.det.2010.03.003_bib16","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1754-4505.2005.tb01656.x","article-title":"Thalidomide in the management of recurrent aphthous ulcerations in patients who are HIV-positive: a review and case reports","volume":"25","author":"Shetty","year":"2005","journal-title":"Spec Care Dentist"},{"issue":"6395","key":"10.1016\/j.det.2010.03.003_bib17","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1136\/bmj.287.6395.799","article-title":"Effect of thalidomide on orogenital ulceration","volume":"287","author":"Bowers","year":"1983","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"6","key":"10.1016\/j.det.2010.03.003_bib18","doi-asserted-by":"crossref","first-page":"443","DOI":"10.7326\/0003-4819-128-6-199803150-00004","article-title":"Thalidomide in the treatment of the mucocutaneous lesions of the Beh\u00e7et syndrome. A randomized, double-blind, placebo-controlled trial","volume":"128","author":"Hamuryudan","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.det.2010.03.003_bib19","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1001\/archderm.118.8.536","article-title":"Thalidomide in the treatment of Behcet's syndrome","volume":"118","author":"Saylan","year":"1982","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2010.03.003_bib20","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/BF02054255","article-title":"Treatment of Behcet's disease with thalidomide","volume":"5","author":"Hamza","year":"1986","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.det.2010.03.003_bib21","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1136\/ard.53.12.828","article-title":"Clinical experience with thalidomide in the management of severe oral and genital ulceration in conditions such as Behcet's disease: use of neurophysiological studies to detect thalidomide neuropathy","volume":"53","author":"Gardner-Medwin","year":"1994","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.det.2010.03.003_bib22","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0248-8663(99)80105-2","article-title":"Treatment of recurrent ulceration with low doses of thalidomide. Pilot study in 17 patients","volume":"20","author":"De Wazi\u00e8res","year":"1999","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.det.2010.03.003_bib23","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/09546630701386993","article-title":"Thalidomide: an experience in therapeutic outcome and adverse reactions","volume":"18","author":"Sharma","year":"2007","journal-title":"J Dermatolog Treat"},{"issue":"3","key":"10.1016\/j.det.2010.03.003_bib24","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/ibd.20317","article-title":"Thalidomide for treatment of intestinal involvement of juvenile-onset Beh\u00e7et disease","volume":"14","author":"Yasui","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.det.2010.03.003_bib25","first-page":"878","article-title":"Fixed lupus erythematosus (its treatment with thalidomide)","volume":"146","author":"Barba-Rubio","year":"1977","journal-title":"Med Cutan Ibero Lat Am"},{"issue":"7","key":"10.1016\/j.det.2010.03.003_bib26","first-page":"489","volume":"145","author":"Lyakhovisky","year":"2006","journal-title":"Harefuah"},{"issue":"4","key":"10.1016\/j.det.2010.03.003_bib27","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1365-2133.1983.tb04600.x","article-title":"Thalidomide in the treatment of sixty cases of chronic discoid lupus erythematosus","volume":"108","author":"Knop","year":"1983","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2010.03.003_bib28","first-page":"1429","article-title":"Thalidomide in the treatment of cutaneous lupus refractory to conventional therapy","volume":"27","author":"Ordi-Ros","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1016\/j.det.2010.03.003_bib29","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1001\/archderm.119.10.812","article-title":"Chronic cutaneous lupus erythematosus. Thalidomide treatment of 11 patients","volume":"119","author":"Hasper","year":"1983","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2010.03.003_bib30","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/rheumatology\/36.3.353","article-title":"Thalidomide in the treatment of the cutaneous manifestations of lupus erythematosus: experience in sixteen consecutive patients","volume":"36","author":"Stevens","year":"1997","journal-title":"Br J Rheumatol"},{"issue":"6","key":"10.1016\/j.det.2010.03.003_bib31","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2165\/00128071-200304060-00002","article-title":"Thalidomide in cutaneous lupus erythematosus","volume":"4","author":"Pelle","year":"2003","journal-title":"Am J Clin Dermatol."},{"issue":"8","key":"10.1016\/j.det.2010.03.003_bib32","first-page":"769","article-title":"A case series of 48 patients treated with thalidomide","volume":"7","author":"Doherty","year":"2008","journal-title":"J Drugs Dermatol"},{"issue":"6","key":"10.1016\/j.det.2010.03.003_bib33","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1191\/0961203305lu2124oa","article-title":"Long-term thalidomide use in refractory cutaneous lesions of lupus erythematosus: a 65 series of Brazilian patients","volume":"14","author":"Coelho","year":"2005","journal-title":"Lupus"},{"issue":"5 Pt 1","key":"10.1016\/j.det.2010.03.003_bib34","first-page":"830","article-title":"Guidelines of care for cutaneous lupus erythematosus. American Academy of Dermatology","volume":"34","author":"Drake","year":"1996","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.det.2010.03.003_bib35","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1046\/j.1365-4362.2003.01184.x","article-title":"Treatment of prurigo nodularis with thalidomide: a case report and review of the literature","volume":"42","author":"Alfadley","year":"2003","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.det.2010.03.003_bib36","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/cpt196563303","article-title":"Thalidomide in the treatment of lepra reactions","volume":"6","author":"Sheskin","year":"1965","journal-title":"Clin Pharmacol Ther"},{"issue":"38","key":"10.1016\/j.det.2010.03.003_bib37","first-page":"3028","volume":"155","author":"J\u00f8hnke","year":"1993","journal-title":"Ugeskr Laeger"},{"issue":"4","key":"10.1016\/j.det.2010.03.003_bib38","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1159\/000245988","article-title":"Sequential\u00a0combined therapy with thalidomide and narrow-band (TL01) UVB in the treatment of\u00a0prurigo nodularis","volume":"195","author":"Ferr\u00e1ndiz","year":"1997","journal-title":"Dermatology"},{"issue":"9","key":"10.1016\/j.det.2010.03.003_bib39","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/j.1365-4362.1984.tb05696.x","article-title":"Thalidomide therapy for inflammatory dermatoses","volume":"23","author":"Grosshans","year":"1984","journal-title":"Int J Dermatol"},{"issue":"10","key":"10.1016\/j.det.2010.03.003_bib40","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.2165\/00003495-200868100-00003","article-title":"Evidence-based therapy for cutaneous sarcoidosis","volume":"68","author":"Doherty","year":"2008","journal-title":"Drugs"},{"key":"10.1016\/j.det.2010.03.003_bib41","first-page":"963","article-title":"Cutaneous sarcoidosis. Treatment with thalidomide","volume":"12","author":"Barriere","year":"1983","journal-title":"Presse Med"},{"key":"10.1016\/j.det.2010.03.003_bib42","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0248-8663(97)80724-2","article-title":"Effectiveness of thalidomide treatment during cutaneous sarcoidosis","volume":"19","author":"Grasland","year":"1998","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.det.2010.03.003_bib43","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0190-9622(98)70360-3","article-title":"Disfiguring cutaneous manifestation of sarcoidosis treated with thalidomide: a case report","volume":"39","author":"Lee","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.det.2010.03.003_bib44","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/0190-9622(95)91549-4","article-title":"Treatment of cutaneous and pulmonary sarcoidosis with thalidomide","volume":"32","author":"Carlesimo","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.det.2010.03.003_bib45","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1001\/archderm.134.8.1045","article-title":"Cutaneous sarcoidosis successfully treated with low dose of thalidomide","volume":"134","author":"Rousseau","year":"1998","journal-title":"Arch Dermatol"},{"issue":"1","key":"10.1016\/j.det.2010.03.003_bib46","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1378\/chest.122.1.227","article-title":"Thalidomide for chronic sarcoidosis","volume":"122","author":"Baughman","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.det.2010.03.003_bib47","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1006\/clim.2001.5173","article-title":"Thalidomide induces granuloma differentiation in sarcoid skin lesions associated with disease improvement","volume":"102","author":"Oliver","year":"2002","journal-title":"Clin Immunol"},{"issue":"5","key":"10.1016\/j.det.2010.03.003_bib48","first-page":"611","article-title":"Sarcoidosis: thalidomide treatment in ten patients","volume":"128","author":"Estines","year":"2001","journal-title":"Ann Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.det.2010.03.003_bib49","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jaad.2006.06.019","article-title":"Cutaneous sarcoidosis therapy updated","volume":"56","author":"Badgwell","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.det.2010.03.003_bib50","first-page":"174","article-title":"Involvement of T-cells and alterations in T-cell receptors in sarcoidosis","volume":"13","author":"Moller","year":"1998","journal-title":"Semin Respir Infect"},{"key":"10.1016\/j.det.2010.03.003_bib51","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1365-2249.1995.tb05527.x","article-title":"The immunosuppressive drug thalidomide induces T helper cell type 2 (Th2) and concomitantly inhibits Th1 cytokine production in mitogen- and antigen-stimulated human peripheral blood mononuclear cell cultures","volume":"99","author":"McHugh","year":"1995","journal-title":"Clin Exp Immunol"},{"issue":"5","key":"10.1016\/j.det.2010.03.003_bib52","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1365-4362.1973.tb00066.x","article-title":"Thalidomide in the treatment of actinic prurigo","volume":"12","author":"Londo\u00f1o","year":"1973","journal-title":"Int J Dermatol"},{"issue":"4","key":"10.1016\/j.det.2010.03.003_bib53","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1365-2230.1977.tb01577.x","article-title":"Actinic prurigo (Hutchinson's summer prurigo)","volume":"2","author":"Calnan","year":"1977","journal-title":"Clin Exp Dermatol"},{"issue":"4","key":"10.1016\/j.det.2010.03.003_bib54","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1365-2133.1983.tb04601.x","article-title":"Thalidomide in actinic prurigo","volume":"108","author":"Lovell","year":"1983","journal-title":"Br J Dermatol"},{"issue":"8577","key":"10.1016\/j.det.2010.03.003_bib55","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(88)90312-1","article-title":"Successful treatment with thalidomide of acute graft-versus-host disease after bone-marrow transplantation","volume":"1","author":"Lim","year":"1988","journal-title":"Lancet"},{"issue":"16","key":"10.1016\/j.det.2010.03.003_bib56","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1056\/NEJM199204163261604","article-title":"Thalidomide for the treatment of chronic graft-versus-host disease","volume":"326","author":"Vogelsang","year":"1992","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.det.2010.03.003_bib57","first-page":"86","article-title":"Paradoxical effect of thalidomide prophylaxis on chronic graft-vs.-host disease","volume":"2","author":"Chao","year":"1996","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"10.1016\/j.det.2010.03.003_bib58","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1053\/bbmt.2001.v7.pm11400948","article-title":"Randomized clinical trial of thalidomide, cyclosporine, and prednisone versus cyclosporine and prednisone as initial therapy for chronic graft-versus-host disease","volume":"7","author":"Arora","year":"2001","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"10.1016\/j.det.2010.03.003_bib59","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/sj.bmt.1704033","article-title":"Thalidomide after allogeneic haematopoietic stem cell transplantation: activity in chronic but not in acute graft-versus-host disease","volume":"32","author":"Kulkarni","year":"2003","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"10.1016\/j.det.2010.03.003_bib60","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00277-007-0410-7","article-title":"Life-threatening acute pancreatitis due to thalidomide therapy for chronic graft-versus-host disease","volume":"87","author":"Chung","year":"2008","journal-title":"Ann Hematol"},{"key":"10.1016\/j.det.2010.03.003_bib61","first-page":"1387","article-title":"Histiocytose X avec \u2018granulome eosinophile vulvaire\u2019: effet spectaculaire de la thalidomide","volume":"114","author":"Gnassia","year":"1987","journal-title":"Ann Dermatol Venereol"},{"issue":"10","key":"10.1016\/j.det.2010.03.003_bib62","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/archderm.129.10.1261","article-title":"Successful treatment of adult's Langerhans cell histiocytosis with thalidomide. Report of two cases and literature review","volume":"129","author":"Thomas","year":"1993","journal-title":"Arch Dermatol"},{"issue":"5","key":"10.1016\/j.det.2010.03.003_bib63","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1365-2230.1993.tb02262.x","article-title":"Remission of Langerhans cell histiocytosis with thalidomide treatment","volume":"18","author":"Misery","year":"1993","journal-title":"Clin Exp Dermatol"},{"issue":"3","key":"10.1016\/j.det.2010.03.003_bib64","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/01.pgp.0000130042.31203.b0","article-title":"Isolated vulvar Langerhans cell histiocytosis: report of two cases","volume":"23","author":"Padula","year":"2004","journal-title":"Int J Gynecol Pathol"},{"issue":"5","key":"10.1016\/j.det.2010.03.003_bib65","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2165\/00128071-200708050-00007","article-title":"Multisystem Langerhans cell histiocytosis: successful treatment with thalidomide","volume":"8","author":"Broekaert","year":"2007","journal-title":"Am J Clin Dermatol"},{"issue":"6","key":"10.1016\/j.det.2010.03.003_bib66","doi-asserted-by":"crossref","first-page":"13","DOI":"10.5070\/D357H5M3SD","article-title":"An unusual case of adult disseminated cutaneous Langerhans cell histiocytosis","volume":"12","author":"Moravvej","year":"2006","journal-title":"Dermatol Online J"},{"issue":"1","key":"10.1016\/j.det.2010.03.003_bib67","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/pbc.20578","article-title":"A phase II trial using thalidomide for Langerhans cell histiocytosis","volume":"48","author":"McClain","year":"2007","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"10.1016\/j.det.2010.03.003_bib68","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2340\/0001555562449450","article-title":"Thalidomide treatment of recurrent erythema multiforme","volume":"62","author":"Bahmer","year":"1982","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"10.1016\/j.det.2010.03.003_bib69","first-page":"40","article-title":"Thalidomide as elective treatment in persistent erythema multiforme; report of two cases","volume":"2","author":"Conejo-Mir","year":"2003","journal-title":"J Drugs Dermatol"},{"issue":"6-7","key":"10.1016\/j.det.2010.03.003_bib70","first-page":"375","article-title":"Treatment by thalidomide of chronic multiforme erythema: its recurrent and continuous variants. A retrospective study of 26 patients","volume":"123","author":"Cherouati","year":"1996","journal-title":"Ann Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.det.2010.03.003_bib71","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1365-2230.2008.03046.x","article-title":"Treatment of cutaneous lichen planus with thalidomide","volume":"34","author":"Moura","year":"2009","journal-title":"Clin Exp Dermatol"},{"issue":"12 Pt 1","key":"10.1016\/j.det.2010.03.003_bib72","first-page":"1109","article-title":"Treatment of erosive oral lichen planus with thalidomide","volume":"130","author":"Macario-Barrel","year":"2003","journal-title":"Ann Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.det.2010.03.003_bib73","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1001\/archderm.143.4.511","article-title":"Oral lichen planus: a case series with emphasis on therapy","volume":"143","author":"Torti","year":"2007","journal-title":"Arch Dermatol"},{"issue":"6","key":"10.1016\/j.det.2010.03.003_bib74","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1067\/mjd.2002.125073","article-title":"Thalidomide-induced remission of lichen planopilaris","volume":"47","author":"Boyd","year":"2002","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.det.2010.03.003_bib75","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1067\/mjd.2001.119559","article-title":"Lichen planopilaris treated with thalidomide","volume":"45","author":"George","year":"2001","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.det.2010.03.003_bib76","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0190-9622(03)00849-1","article-title":"Thalidomide is ineffective in the treatment of lichen planopilaris","volume":"51","author":"Jouanique","year":"2004","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.det.2010.03.003_bib77","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/clinids\/23.3.501","article-title":"Regression of AIDS-related Kaposi's sarcoma during therapy with thalidomide","volume":"23","author":"Sol\u00e8r","year":"1996","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.det.2010.03.003_bib78","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1258\/0956462981921512","article-title":"Activity of thalidomide in AIDS-related Kaposi's sarcoma and correlation with HHV8 titre","volume":"9","author":"Fife","year":"1998","journal-title":"Int J STD AIDS"},{"issue":"13","key":"10.1016\/j.det.2010.03.003_bib79","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1200\/JCO.2000.18.13.2593","article-title":"Activity of thalidomide in AIDS-related Kaposi's sarcoma","volume":"18","author":"Little","year":"2000","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.det.2010.03.003_bib80","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000106576","article-title":"A retrospective analysis of thalidomide therapy in non-HIV-related Kaposi's sarcoma","volume":"215","author":"Ben M'barek","year":"2007","journal-title":"Dermatology"},{"issue":"3","key":"10.1016\/j.det.2010.03.003_bib81","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1159\/000106583","article-title":"Thalidomide in the treatment of Kaposi's sarcoma","volume":"215","author":"Rubegni","year":"2007","journal-title":"Dermatology"},{"issue":"8","key":"10.1016\/j.det.2010.03.003_bib82","first-page":"611","article-title":"Treatment of Jessner-Kanof disease with thalidomide","volume":"110","author":"Moulin","year":"1983","journal-title":"Ann Dermatol Venereol."},{"issue":"9","key":"10.1016\/j.det.2010.03.003_bib83","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1001\/archderm.131.9.1032","article-title":"Crossover study of thalidomide vs placebo in Jessner's lymphocytic infiltration of the skin","volume":"131","author":"Guillaume","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2010.03.003_bib84","series-title":"Manual of dermatologic therapeutics","first-page":"167","article-title":"Pruritus","author":"Arndt","year":"2002"},{"issue":"3","key":"10.1016\/j.det.2010.03.003_bib85","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1159\/000187978","article-title":"Thalidomide for the treatment of uremic pruritus: a crossover randomized double-blind trial","volume":"67","author":"Silva","year":"1994","journal-title":"Nephron"},{"issue":"7","key":"10.1016\/j.det.2010.03.003_bib86","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1080\/10428190701361224","article-title":"IgG multiple myeloma presented with ulcerative pyoderma gangrenosum","volume":"48","author":"Verrou","year":"2007","journal-title":"Leuk Lymphoma"},{"issue":"11","key":"10.1016\/j.det.2010.03.003_bib87","first-page":"422","article-title":"Successful treatment of myelodysplastic syndrome-induced pyoderma gangrenosum","volume":"64","author":"Koca","year":"2006","journal-title":"Neth J Med"},{"issue":"8","key":"10.1016\/j.det.2010.03.003_bib88","doi-asserted-by":"crossref","first-page":"842","DOI":"10.4065\/75.8.842","article-title":"Recalcitrant pyoderma gangrenosum treated with thalidomide","volume":"75","author":"Federman","year":"2000","journal-title":"Mayo Clin Proc"},{"issue":"9","key":"10.1016\/j.det.2010.03.003_bib89","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1177\/014107689008300918","article-title":"Pyoderma gangrenosum with severe pharyngeal ulceration","volume":"83","author":"Buckley","year":"1990","journal-title":"J R Soc Med"},{"key":"10.1016\/j.det.2010.03.003_bib90","first-page":"67","article-title":"Pyoderma gangrenosum in a child: treatment with thalidomide","volume":"29","author":"Venencie","year":"1982","journal-title":"Ann Pediatr"},{"key":"10.1016\/j.det.2010.03.003_bib91","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0190-9622(98)70513-4","article-title":"Recalcitrant pyoderma gangrenosum: treatment with thalidomide","volume":"38","author":"Hecker","year":"1998","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.det.2010.03.003_bib92","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1046\/j.1365-2133.1998.02087.x","article-title":"Pyoderma gangrenosum of the penis","volume":"138","author":"Farrell","year":"1998","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.det.2010.03.003_bib93","first-page":"408","article-title":"Pyoderma gangrenosum associated with Beh\u00e7et's syndrome\u2014response to thalidomide","volume":"13","author":"Munro","year":"1988","journal-title":"Clin Exp Dermatol"},{"issue":"10","key":"10.1016\/j.det.2010.03.003_bib94","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1002\/art.20559","article-title":"Therapeutic management of pyoderma gangrenosum","volume":"50","author":"Ehling","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.det.2010.03.003_bib95","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/j.1365-2230.2008.02744.x","article-title":"Scleromyxoedema with associated peripheral neuropathy: successful treatment with thalidomide","volume":"33","author":"Peter","year":"2008","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"10.1016\/j.det.2010.03.003_bib96","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000096914","article-title":"Scleromyxedema: successful treatment with thalidomide in two patients","volume":"214","author":"Amini-Adle","year":"2007","journal-title":"Dermatology"},{"issue":"2","key":"10.1016\/j.det.2010.03.003_bib97","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1468-3083.2008.02766.x","article-title":"Scleromyxedema with myopathy was successfully treated by thalidomide","volume":"23","author":"Wu","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.det.2010.03.003_bib98","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jaad.2004.01.058","article-title":"Treatment of recalcitrant scleromyxedema with thalidomide in 3 patients","volume":"51","author":"Sansbury","year":"2004","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.det.2010.03.003_bib99","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1001\/archderm.142.1.20","article-title":"Thalidomide for the treatment of refractory necrobiosis lipoidica","volume":"142","author":"Kukreja","year":"2006","journal-title":"Arch Dermatol"},{"issue":"9140","key":"10.1016\/j.det.2010.03.003_bib100","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/S0140-6736(98)02197-7","article-title":"Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis","volume":"352","author":"Wolkenstein","year":"1998","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.det.2010.03.003_bib101","first-page":"194","article-title":"Management of thalidomide toxicity","volume":"1","author":"Ghobrial","year":"2003","journal-title":"J Support Oncol"},{"issue":"1","key":"10.1016\/j.det.2010.03.003_bib102","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/tera.1420160113","article-title":"Thalidomide embryopathy","volume":"16","author":"Mcbride","year":"1977","journal-title":"Teratology"},{"issue":"12","key":"10.1016\/j.det.2010.03.003_bib103","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1212\/01.WNL.0000131766.90137.DF","article-title":"Thalidomide neuropathy: too much or too long?","volume":"62","author":"Apfel","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.det.2010.03.003_bib104","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1212\/WNL.62.12.2291","article-title":"Thalidomide sensory neurotoxicity: a clinical and neurophysiological study","volume":"62","author":"Cavaletti","year":"2004","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.det.2010.03.003_bib105","first-page":"765","article-title":"Frequency of thromboembolic events associated with thalidomide in the non-cancer setting: a case report and review of the literature","volume":"8","author":"Fabi","year":"2009","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.det.2010.03.003_bib106","series-title":"Thalidomide","year":"2003"},{"key":"10.1016\/j.det.2010.03.003_bib107","first-page":"625","article-title":"Thalidomide and exfoliative dermatitis","volume":"56","author":"Salafi","year":"1988","journal-title":"Int J Lepr"},{"key":"10.1016\/j.det.2010.03.003_bib108","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0079-6468(08)70231-5","article-title":"Thalidomide and congeners as anti-inflammatory agents","volume":"22","author":"Koch","year":"1985","journal-title":"Prog Med Chem"}],"container-title":["Dermatologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863510000446?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863510000446?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T08:55:06Z","timestamp":1740128106000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733863510000446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":108,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S0733863510000446"],"URL":"https:\/\/doi.org\/10.1016\/j.det.2010.03.003","relation":{},"ISSN":["0733-8635"],"issn-type":[{"value":"0733-8635","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}